DrugPatentWatch Database Preview
Try a free trial
See Plans and Pricing
« Back to Dashboard
Apadaz is a drug marketed by Kvk Tech Inc and is included in one NDA. There are five patents protecting this drug.
This drug has thirty-two patent family members in nineteen countries.
The generic ingredient in APADAZ is acetaminophen; benzhydrocodone hydrochloride. There are sixty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the acetaminophen; benzhydrocodone hydrochloride profile page.
Generic Entry Opportunity Date for APADAZ
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Synonyms for APADAZ
|Acetaminophen / benzhydrocodone hydrochloride|
|Acetaminophen and benzhydrocodone hydrochloride|
|Acetaminophen mixture with benzhydrocodone hydrochloride|
|Country||Patent Number||Estimated Expiration|
|Mexico||2012000128||Try a Free Trial|
|China||102480959||Try a Free Trial|
|Japan||2012532142||Try a Free Trial|
|Ukraine||102916||Try a Free Trial|
|South Korea||20180081176||Try a Free Trial|
|Israel||259889||Try a Free Trial|
|>Country||>Patent Number||>Estimated Expiration|